{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T10:32:40Z","timestamp":1791282760508,"version":"4.1.0"},"reference-count":208,"publisher":"Oxford University Press (OUP)","issue":"2","license":[{"start":{"date-parts":[[1992,5,1]],"date-time":"1992-05-01T00:00:00Z","timestamp":704678400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2008,6,28]]},"abstract":"<jats:title>SUMMARY<\/jats:title><jats:p>In this review B cell responses in HIV-infected individuals are summarized together with the techniques used to date to produce human monoclonals to HIV and the properties of these antibodies. Profound disturbances in B cell responses are apparent both in vivo and in vitro. While there is evidence in vivo of marked polyclonal B cell activation, primary and secondary antibody responses are impaired. Similarly these cells exhibit spontaneous immunoglobulin secretion upon in vitro culture but do not readily respond to B cell mitogens and recall antigens including HIV. Furthermore, certain of these defects can be reproduced in normal B cells in vitro by incubation with HIV or HIV coded peptides. Individuals infected with HIV develop antibodies to HIV structural proteins (e.g. p17, p24, gp41 and gp120) and regulatory proteins (e.g. vif, nef, RT). Autoantibodies against a number of immunologically important molecules are also frequently observed. The anti-HIV antibodies are predominantly of the IgG1 isotype and exhibit a variety of effects on the virus in vitro. To date, using conventional immortalization strategies, an appreciable number of human monoclonals to HIV have been developed. These have been specific for gp41, gp120 and gag with antibodies of the former specificity predominating. The majority of these antibodies have been of the IgGl isotype. Only a small number of the antibodies neutralize virus in vitro and most of these react with gp120. The neutralizing antibodies recognize conformational and carbohydrate epitopes or epitopes in amino acid positions 306\u2013322. The predominant epitopes recognized by the anti-gp41 antibodies were in amino acid positions 579\u2013620 and 644\u2013662. A high percentage (\u224f 25%) of these antibodies enhance viral growth in vitro. The problems relating to the production of human monoclonals to HIV are discussed together with strategies that could be used in the future.<\/jats:p>","DOI":"10.1111\/j.1365-2249.1992.tb03061.x","type":"journal-article","created":{"date-parts":[[2010,7,26]],"date-time":"2010-07-26T19:06:24Z","timestamp":1280171184000},"page":"189-202","source":"Crossref","is-referenced-by-count":14,"title":["B cell responses to HIV and the development of human monoclonal antibodies"],"prefix":"10.1093","volume":"88","author":[{"given":"J E","family":"BOYD","sequence":"first","affiliation":[{"name":"Department of Surgery, University Medical School, Edinburgh, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K","family":"JAMES","sequence":"additional","affiliation":[{"name":"Department of Surgery, University Medical School, Edinburgh, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2008,6,28]]},"reference":[{"key":"2022011703312956800_b1","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1038\/scientificamerican0187-46","article-title":"The AIDS virus. Part II","volume":"256","author":"Gallo","year":"1987","journal-title":"Sci Am"},{"key":"2022011703312956800_b2","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0769-2617(87)80068-0","article-title":"The human immune deficiency virus (HIV): an update","volume":"138","author":"Montagnier","year":"1987","journal-title":"Ann Inst Pasteur Virol"},{"key":"2022011703312956800_b3","first-page":"217","article-title":"Replication and pathogenesis of the AIDS virus","volume":"1","author":"Haseltine","year":"1988","journal-title":"J AIDS"},{"key":"2022011703312956800_b4","doi-asserted-by":"crossref","first-page":"2997","DOI":"10.1001\/jama.1989.03420200087044","article-title":"Human immunodeficiency viruses and the pathogenesis of AIDS","volume":"261","author":"Levy","year":"1989","journal-title":"JAMA"},{"key":"2022011703312956800_b5","first-page":"59","article-title":"Immunopathogenesis of HTLV-III\/LAV infection","volume-title":"Viruses and human cancer","author":"Margolick","year":"1987"},{"key":"2022011703312956800_b6","first-page":"81","article-title":"HIV infection: the cellular picture","volume":"257","author":"Weber","year":"1988","journal-title":"Sci Am"},{"key":"2022011703312956800_b7","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1001\/jama.1984.03340350037024","article-title":"B-cell immunodeficiency in acquired immune deficiency syndrome","volume":"251","author":"Ammann","year":"1984","journal-title":"JAMA"},{"key":"2022011703312956800_b8","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1056\/NEJM198308253090803","article-title":"Abnormalities of B-cell activation and immunoregulation in patients with the acquired immunodeficiency syndrome","volume":"309","author":"Lane","year":"1983","journal-title":"N Engl J Med"},{"key":"2022011703312956800_b9","first-page":"70","article-title":"HIV infection: the clinical picture","volume":"257","author":"Redfield","year":"1988","journal-title":"Sci Am"},{"key":"2022011703312956800_b10","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1111\/j.1365-2249.1991.tb08145.x","article-title":"Antibody responses in HIV infection","volume":"84","author":"Pinching","year":"1991","journal-title":"clin Exp Immunol"},{"key":"2022011703312956800_b11","first-page":"161","article-title":"HTLV-III\/LAV infection of mononuclear phagocyte cells in vivo and in vitro","volume-title":"Viruses and human cancer","author":"Popovic","year":"1987"},{"key":"2022011703312956800_b12","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1126\/science.2460922","article-title":"Infection and replication of HIV-I in purified progenitor cells of normal human bone marrow","volume":"242","author":"Folks","year":"1988","journal-title":"Science"},{"key":"2022011703312956800_b13","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1172\/JCI113924","article-title":"Replication of the human immunodeficiency virus I and impaired differentiation of T cells after in vitro infection of bone marrow immature T cells","volume":"83","author":"Lunardi-Iskander","year":"1989","journal-title":"J Clin Invest"},{"key":"2022011703312956800_b14","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1128\/jvi.65.4.1765-1769.1991","article-title":"In vitro suppression of normal human bone marrow progenitor cells by human immunodeficiency virus","volume":"65","author":"Steinberg","year":"1991","journal-title":"J Virol"},{"key":"2022011703312956800_b15","doi-asserted-by":"crossref","first-page":"3720","DOI":"10.4049\/jimmunol.138.11.3720","article-title":"Infection with the human immunodeficiency virus (HIV) is associated with an in vivo increase in B lymphocyte activation and immaturity","volume":"138","author":"Martinez-Maza","year":"1987","journal-title":"J Immunol"},{"key":"2022011703312956800_b16","first-page":"410","article-title":"B-cell activation in HIV infection: relationship of spontaneous immunoglobulin secretion to various immunological parameters","volume":"71","author":"Mizuma","year":"1988","journal-title":"Clin Exp Immunol"},{"key":"2022011703312956800_b17","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1093\/infdis\/163.5.959","article-title":"Long-term human immunodeficiency virus infection in asymptomatic homosexual and bisexual men with normal CD4+ lymphocyte counts: immunologic and virologic characteristics","volume":"163","author":"Lifson","year":"1991","journal-title":"J Infect Dis"},{"key":"2022011703312956800_b18","first-page":"373A","article-title":"Abnormally elevated frequency of Epstein-Barr virus (EBV)-infected B cells in the blood of patients with acquired immunodeficiency syndrome (AI DS) and AIDS-related complex","volume":"33","author":"Birx","year":"1985","journal-title":"Clin Res"},{"key":"2022011703312956800_b19","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1172\/JCI112595","article-title":"Mechanisms of B cell activation in patients with acquired immunodeficiency syndrome and related disorders","volume":"78","author":"Yarchoan","year":"1986","journal-title":"J Clin Invest"},{"key":"2022011703312956800_b20","first-page":"95","article-title":"Monoclonal antibodies to human immunodeficiency virus: their relation to the patterns of lymph node changes in persistent generalized lymphadenopathy and AIDS","volume":"1","author":"Tenner-Racz","year":"1987","journal-title":"AIDS"},{"key":"2022011703312956800_b21","first-page":"5","article-title":"Serum IgD elevation is an early marker of B cell activation during infection with the human immunodeficiency viruses","volume":"68","author":"Mizuma","year":"1987","journal-title":"Clin Exp Immunol"},{"key":"2022011703312956800_b22","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1097\/00002030-199009000-00004","article-title":"Response to mononuclear cells from HIV-infected patients to B-cell mitogens: correlation with immunological and clinical features of disease progression","volume":"4","author":"Edelman","year":"1990","journal-title":"AIDS"},{"key":"2022011703312956800_b23","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1136\/bmj.295.6593.293","article-title":"Lymphocyte transformation response to pokeweed mitogen as a predictive marker for development of AIDS and AIDS related symptoms in homosexual men with HIV antibodies","volume":"295","author":"Hofmann","year":"1987","journal-title":"Br Med J"},{"key":"2022011703312956800_b24","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1172\/JCI111190","article-title":"Immunoregulatory subsets of the T helper and T suppressor cell populations in homosexual men with chronic unexplained lymphadenopathy","volume":"73","author":"Nicholson","year":"1984","journal-title":"J Clin Invest"},{"key":"2022011703312956800_b25","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1002\/eji.1830190415","article-title":"Longitudinal study of leukocyte functions in homosexual men seroconverted for HIV: rapid and persistent lossof B cell function after HIV infection","volume":"19","author":"Terpstra","year":"1989","journal-title":"Eur J Immunol"},{"key":"2022011703312956800_b26","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1097\/00002030-199107000-00005","article-title":"B cell activation during H1V-I infection III down-regulating effect of mitogens","volume":"5","author":"Amadori","year":"1991","journal-title":"AIDS"},{"key":"2022011703312956800_b27","doi-asserted-by":"crossref","first-page":"1908","DOI":"10.1172\/JCI113809","article-title":"Immunological abnormalities in human immunodeficiency virus (HIV)-infected asymptomatic homosexual men","volume":"82","author":"Miedema","year":"1988","journal-title":"J Clin Invest"},{"key":"2022011703312956800_b28","doi-asserted-by":"crossref","first-page":"2929","DOI":"10.4049\/jimmunol.139.9.2929","article-title":"Analysis of the antigen- and mitogen-induced differentiation of B lymphocytes from asymptomatic human immunodeficiency virus-seropositive male homosexuals","volume":"139","author":"Teeuwsen","year":"1987","journal-title":"J Immunol"},{"key":"2022011703312956800_b29","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1172\/JCI114001","article-title":"Lymphocyte proliferative responses to human immunodeficiency virus antigens in vitro","volume":"83","author":"Krowka","year":"1989","journal-title":"J Clin Invest"},{"key":"2022011703312956800_b30","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1016\/S0006-291X(88)81254-3","article-title":"Human monoclonal antibody against glycoproteins of human immunodeficiency virus","volume":"155","author":"Sugano","year":"1988","journal-title":"Biochem Biophys Res Comm"},{"key":"2022011703312956800_b31","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/0090-1229(88)90053-0","article-title":"Spontaneous in vitro production of virus-specific antibody by lymphocytes from HIV-infected subjects","volume":"46","author":"Amadori","year":"1988","journal-title":"Clin Immunol Immunopathol"},{"key":"2022011703312956800_b32","doi-asserted-by":"crossref","first-page":"2146","DOI":"10.4049\/jimmunol.143.7.2146","article-title":"HIV-1-specific B cell activation. A major constituent of spontaneous B cell activation during H1V-1 infection","volume":"143","author":"Amadori","year":"1989","journal-title":"J Immunol"},{"key":"2022011703312956800_b33","doi-asserted-by":"crossref","first-page":"57","DOI":"10.4049\/jimmunol.146.1.57","article-title":"B cell activation during HIV-1 infection II cell-to-cell interactions and cytokine requirement","volume":"146","author":"Amadori","year":"1991","journal-title":"J Immunol"},{"key":"2022011703312956800_b34","first-page":"1339","article-title":"Lack of in vitro production of anti-p24 antibodies by peripheral blood lymphocytes (PBL) of HIV-I infected patients","volume-title":"VIIth International Conference on AIDS, Florence","author":"Rusconi","year":"1621 1991"},{"key":"2022011703312956800_b35","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1097\/00002030-199108000-00008","article-title":"Low numbers of functionally active B lymphocytes in the peripheral blood of HIV-1-seropositive individuals with low p24\u2013specific serum antibody titers","volume":"5","author":"Teeuwsen","year":"1991","journal-title":"AIDS"},{"key":"2022011703312956800_b36","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/0166-0934(87)90067-X","article-title":"Potential use of serotherapy in the prevention and treatment of infection with the human immunodeficiency virus","volume":"17","author":"Zolla-Pazner","year":"1987","journal-title":"J Virol Methods"},{"key":"2022011703312956800_b37","doi-asserted-by":"crossref","first-page":"3972","DOI":"10.1073\/pnas.87.10.3972","article-title":"Polyclonal B-cell activation reveals antibodies against human immunodeficiency virus type 1 (HIV-1) in HIV-1-seronegative individuals","volume":"87","author":"Jehuda-Cohen","year":"1990","journal-title":"Proc Natl Acad Sci USA"},{"key":"2022011703312956800_b38","doi-asserted-by":"crossref","first-page":"7532","DOI":"10.1073\/pnas.86.19.7532","article-title":"In vitro synthesis of human immunodeficiency virus-specific antibodies in peripheral blood lymphocytes of infants","volume":"86","author":"Pahwa","year":"1989","journal-title":"Proc Natl Acad Sci USA"},{"key":"2022011703312956800_b39","doi-asserted-by":"crossref","first-page":"6498","DOI":"10.1073\/pnas.85.17.6498","article-title":"Immunoregulatory activities of human immunodeficiency virus (HIV) proteins: effect of HIV recombinant and synthetic peptides on immunoglobulin synthesis and proliferative responses by normal lymphocytes","volume":"85","author":"Nair","year":"1988","journal-title":"Proc Natl Acad Sci USA"},{"key":"2022011703312956800_b40","doi-asserted-by":"crossref","first-page":"9124","DOI":"10.1073\/pnas.83.23.9124","article-title":"Stimulatory and inhibitory influences of human immunodeficiency virus on normal B lymphocytes","volume":"83","author":"Pahwa","year":"1986","journal-title":"Proc Natl Acad Sci USA"},{"key":"2022011703312956800_b41","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1126\/science.3016902","article-title":"Direct polyclonal activation of human B lymphocytes by the acquired immune deficiency syndrome virus","volume":"233","author":"Schnittman","year":"1986","journal-title":"Science"},{"key":"2022011703312956800_b42","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/0008-8749(88)90052-4","article-title":"Synthetic peptides homologous to HIV transmembrane glycoprotein suppress normal human lymphocyte blastogenic response","volume":"111","author":"Chanh","year":"1988","journal-title":"Cell Immunol"},{"key":"2022011703312956800_b43","doi-asserted-by":"crossref","first-page":"8198","DOI":"10.1073\/pnas.82.23.8198","article-title":"Influence of the human T-lymphotropic virus\/lymphadenopathy-associated virus on functions of human lymphocytes: evidence for immunosuppressive effects and polyclonal B-cell activation by banded viral preparations","volume":"82","author":"Pahwa","year":"1985","journal-title":"Proc Natl Acad Sci USA"},{"key":"2022011703312956800_b44","doi-asserted-by":"crossref","first-page":"2640","DOI":"10.4049\/jimmunol.138.8.2640","article-title":"HTLV-III large envelope protein (gp120) suppresses PHA-induced lymphocyte blastogenesis","volume":"138","author":"Mann","year":"1987","journal-title":"J Immunol"},{"key":"2022011703312956800_b45","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1182\/blood.V75.1.152.152","article-title":"Inhibition of functional properties of tetanus antigen-specific T-cell clones by envelope glycoprotein gp120 of human immunodeficiency virus","volume":"75","author":"Chirmule","year":"1990","journal-title":"Blood"},{"key":"2022011703312956800_b46","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/0008-8749(87)90108-0","article-title":"The effects of human immunodeficiency virus recombinant envelope glycoprotein on immune cell functions in vitro","volume":"110","author":"Shalaby","year":"1987","journal-title":"Cell Immunol"},{"key":"2022011703312956800_b47","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1126\/science.2556795","article-title":"Inhibition of antigen-induced lymphocyte proliferation by tat protein from HIV-1","volume":"246","author":"Viscidi","year":"1989","journal-title":"Science"},{"key":"2022011703312956800_b48","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/0008-8749(88)90161-X","article-title":"Inhibition of normal human natural killer cell activity by human immunodeficiency virus synthetic transmembrane peptides","volume":"115","author":"Cauda","year":"1988","journal-title":"Cell Immunol"},{"key":"2022011703312956800_b49","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1038\/335639a0","article-title":"Neuronal cell killing by the envelope protein of HIV and its prevention by vasoactive intestinal peptide","volume":"335","author":"Brenneman","year":"1988","journal-title":"Nature"},{"key":"2022011703312956800_b50","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1212\/WNL.40.11.1757","article-title":"Neuronal injury due to HIV-1 envelope protein is blocked by anti-gp120 antibodies but not by anti-CD4 antibodies","volume":"40","author":"Kaiser","year":"1990","journal-title":"Neurology"},{"key":"2022011703312956800_b51","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1016\/S0140-6736(88)91713-8","article-title":"Cellular anti-gp120 cytolytic reactivities in HIV-1 seropositive individuals","volume":"i","author":"Weinhold","year":"1988","journal-title":"Lancet"},{"key":"2022011703312956800_b52","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1089\/aid.1990.6.299","article-title":"Localization of B-cell stimulatory activity of HIV-1 to the carboxyl terminus of gp41","volume":"6","author":"Chirmule","year":"1990","journal-title":"AIDS Res Hum Retroviruses"},{"key":"2022011703312956800_b53","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/0167-5699(84)90219-6","article-title":"Do natural killer cells regulate B-cell activity","volume":"5","author":"James","year":"1984","journal-title":"Immunol Today"},{"key":"2022011703312956800_b54","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/0042-6822(87)90120-6","article-title":"Heterogeneity of human immunodeficiency virus cell-associated antigens and demonstration of virus type specificities ofhuman antibody responses","volume":"161","author":"Cloyd","year":"1987","journal-title":"Virology"},{"key":"2022011703312956800_b55","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1089\/aid.1987.3.95","article-title":"Analysis of human serum antibodies to human immunodeficiency virus (HIV) using recombinant ENV and GAG antigens","volume":"3","author":"Kenealy","year":"1987","journal-title":"AIDS Res Hum Retroviruses"},{"key":"2022011703312956800_b56","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1136\/bmj.293.6560.1459","article-title":"Persistent HIV antigenaemia and decline of HIV core antibodies associated with transition to AIDS","volume":"293","author":"Lange","year":"1986","journal-title":"Br Med J"},{"key":"2022011703312956800_b57","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1089\/aid.1990.6.443","article-title":"Prevalence of antibodies to the core protein p17, a serological marker during HIV-1 infection","volume":"6","author":"Mehta","year":"1990","journal-title":"AIDS Res Hum Retroviruses"},{"key":"2022011703312956800_b58","doi-asserted-by":"crossref","first-page":"114","DOI":"10.4049\/jimmunol.141.1.114","article-title":"Restricted heterogeneity of antibody to gp120 and p24 in AIDS","volume":"141","author":"Grimaldi","year":"1988","journal-title":"J Immunol"},{"key":"2022011703312956800_b59","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1182\/blood.V77.5.1118.1118","article-title":"Monitoring of specific antibodies to human immunodeficiency virus structural proteins: clinical significance","volume":"77","author":"Allain","year":"1991","journal-title":"Blood"},{"key":"2022011703312956800_b60","first-page":"1342","article-title":"Antibodies to HIV reverse transcriptase as prognostic factors","volume-title":"VIIth International Conference on AIDS, Florence","author":"Bentwich","year":"1621 1991"},{"key":"2022011703312956800_b61","first-page":"1351","article-title":"Serum reactivity to the HIV-1 endonuclease is directed to a unique antigenic site","volume-title":"VIIth International Conference on AIDS, Florence","author":"Bjorling","year":"1621 1991"},{"key":"2022011703312956800_b62","first-page":"1329","article-title":"Significance of serology on antibody reactive to HIV-1 negative factor (nef) gene product using sera from HIV-1 infected hemophiliac patients","volume-title":"VIIth International Conference on AIDS, Florence","author":"Ikegami","year":"1621 1991"},{"key":"2022011703312956800_b63","doi-asserted-by":"crossref","first-page":"2415","DOI":"10.1128\/jcm.25.12.2415-2417.1987","article-title":"Antibody that inhibits human immunodeficiency virus reverse transcriptase and association with inability to isolate virus","volume":"25","author":"Sano","year":"1987","journal-title":"J Clin Microbiol"},{"key":"2022011703312956800_b64","first-page":"1353","article-title":"Epitopes of the HIV-1 vif protein as recognized by human sera and murine monoclonal antibodies","volume-title":"VIIth International Conference on AIDS, Florence","author":"Wieland","year":"1621 1991"},{"key":"2022011703312956800_b65","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/0002-9343(85)90405-X","article-title":"Anti-lymphocyte antibodies in patients with the acquired immune deficiency syndrome","volume":"78","author":"Dorsett","year":"1985","journal-title":"Am J Med"},{"key":"2022011703312956800_b66","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1056\/NEJM198506063122312","article-title":"Antilymphocyte antibodies and seropositivity for retroviruses in groups at high risk for AIDS","volume":"312","author":"Kiprov","year":"1985","journal-title":"N Engl J Med"},{"key":"2022011703312956800_b67","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1007\/BF00916007","article-title":"The significance of antilymphocyte antibodies in patients with acquired immune deficiency syndrome (AIDS) and their sexual partners","volume":"7","author":"Ozturk","year":"1987","journal-title":"J Clin Immunol"},{"key":"2022011703312956800_b68","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/0090-1229(89)90061-5","article-title":"Isotype, distribution and target analysis of lymphocyte reactive antibodies in patients with human immunodeficiency virus infection","volume":"53","author":"Silvestris","year":"1989","journal-title":"Clin Immunol Immunopathol"},{"key":"2022011703312956800_b69","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1038\/327710a0","article-title":"An AIDS-related cytotoxic autoantibody reacts with a specific antigen on stimulated CD4+ T cells","volume":"327","author":"Stricker","year":"1987","journal-title":"Nature"},{"key":"2022011703312956800_b70","first-page":"611","article-title":"Individuals infected with HIV possess antibodies against IL-2","volume":"65","author":"Bost","year":"1988","journal-title":"Immunology"},{"key":"2022011703312956800_b71","doi-asserted-by":"crossref","first-page":"9188","DOI":"10.1073\/pnas.83.23.9188","article-title":"Sequence homology between acquired immunodeficiency syndrome virus envelope protein and interleukin 2","volume":"83","author":"Reiher","year":"1986","journal-title":"Proc Natl Acad Sci USA"},{"key":"2022011703312956800_b72","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1084\/jem.167.3.914","article-title":"Identification of homologous regions in human immunodeficiency virus I gp41 and human MHC Class II B1 domain","volume":"167","author":"Golding","year":"1988","journal-title":"J Exp Med"},{"key":"2022011703312956800_b73","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1172\/JCI114034","article-title":"Common epitope in human immunodeficiency virus (HIV) 1-gp41 and HLA class II elicits immunosuppressive autoantibodies capable of contributing to immune dysfunction in HIV 1-infected individuals","volume":"83","author":"Golding","year":"1989","journal-title":"J Clin Invest"},{"key":"2022011703312956800_b74","doi-asserted-by":"crossref","first-page":"5225","DOI":"10.1073\/pnas.85.14.5225","article-title":"Presence of antibodies to a putatively immunosuppressive part of human immunodeficiency virus (HIV) envelope glycoprotein gp41 is strongly associated with health among HIV-positive subjects","volume":"85","author":"Klasse","year":"1988","journal-title":"Proc Natl Acad Sci USA"},{"key":"2022011703312956800_b75","first-page":"1243","article-title":"Role of anti-FAB autoantibodies in HIV-infected hemophilia patients","volume-title":"VIIth International Conference on AIDS, Florence","author":"Susal","year":"1621 1991"},{"key":"2022011703312956800_b76","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1097\/00002030-199105000-00014","article-title":"Biological properties of anti-CD4 autoantibodies purified from HIV-infected patients","volume":"5","author":"Chams","year":"1991","journal-title":"AIDS"},{"key":"2022011703312956800_b77","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1089\/aid.1988.4.3","article-title":"Isotypic restriction of the antibody response to human immunodeficiency virus","volume":"4","author":"Khalife","year":"1988","journal-title":"AIDS Res Hum Retroviruses"},{"key":"2022011703312956800_b78","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1093\/infdis\/156.6.1026","article-title":"Patterns of antibodies to human immunodeficiency virus proteins in different subclasses of IgG","volume":"156","author":"Klasse","year":"1987","journal-title":"J Infect Dis"},{"key":"2022011703312956800_b79","first-page":"343","article-title":"IgG subclass response to HIV in relation to antibody-dependent cellular cytotoxicity at different clinical stages","volume":"73","author":"Ljunggren","year":"1988","journal-title":"Clin Exp Immunol"},{"key":"2022011703312956800_b80","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1002\/jmv.1890250104","article-title":"IgG subclass reactivity against human immunodeficiency virus (HIV) and cytomegalovirus in cerebrospinal fluid and serum from HIV-infected patients","volume":"25","author":"Mathiesen","year":"1988","journal-title":"J Med Virol"},{"key":"2022011703312956800_b81","first-page":"453","article-title":"Mapping of IgG subclass and T-cell epitopes on HIV proteins by synthetic peptides","volume":"67","author":"Mathiesen","year":"1989","journal-title":"Immunology"},{"key":"2022011703312956800_b82","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1093\/infdis\/153.5.970","article-title":"Restricted IgG subclass responses to HTLV-III\/LAV and to cytomegalovirus in patients with AIDS and lymphadenopathy syndrome","volume":"153","author":"Sundqvist","year":"1986","journal-title":"J Infect Dis"},{"key":"2022011703312956800_b83","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1089\/aid.1989.5.525","article-title":"Cross-neutralizing antibodies against HIV-1 (HTLV-IIIB and HTLV-IIIRF) and HIV-2 (SBL-6669 and a new isolate SBL-K135)","volume":"5","author":"Bottiger","year":"1989","journal-title":"AIDS Res Hum Retroviruses"},{"key":"2022011703312956800_b84","doi-asserted-by":"crossref","first-page":"2815","DOI":"10.1073\/pnas.85.8.2815","article-title":"Identification of human immunodeficiency virus subtypes with distinct patterns of sensitivity to serum neutralization","volume":"85","author":"Cheng-Mayor","year":"1988","journal-title":"Proc Natl Acad Sci USA"},{"key":"2022011703312956800_b85","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1038\/324572a0","article-title":"Variable and conserved neutralization antigens of human immunodeficiency virus","volume":"324","author":"Weiss","year":"1986","journal-title":"Nature"},{"key":"2022011703312956800_b86","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1089\/aid.1987.3.71","article-title":"Characterization of serum neutralization response to the human immunodeficiency virus (HIV)","volume":"3","author":"Groopman","year":"1987","journal-title":"AIDS Res Hum Retroviruses"},{"key":"2022011703312956800_b87","first-page":"231","article-title":"Neutralizing antibodies in HIV (HTLV-III) infection: correlation with clinical outcome and antibody response against different viral proteins","volume":"69","author":"Ranki","year":"1987","journal-title":"Clin Exp Immunol"},{"key":"2022011703312956800_b88","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1093\/infdis\/161.2.198","article-title":"Antibodies mediating cellular cytotoxicity and neutralization correlate with a better clinical stage in children born to human immunodeficiency virus-infected mothers","volume":"161","author":"Ljunggren","year":"1990","journal-title":"J Infect Dis"},{"key":"2022011703312956800_b89","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1203\/00006450-198706000-00008","article-title":"Relationship between HTLV-III neutralizing antibody and clinical status of pediatric acquired immunodeficiency syndrome (AIDS) and AIDS-related complex cases","volume":"21","author":"Robert-Guroff","year":"1987","journal-title":"Pediatric Res"},{"key":"2022011703312956800_b90","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1089\/aid.1987.3.157","article-title":"Neutralizing antibodies and the course of HIV-induced disease","volume":"3","author":"Wendler","year":"1987","journal-title":"AIDS Res Hum Retroviruses"},{"key":"2022011703312956800_b91","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1093\/infdis\/156.2.268","article-title":"Prevalence, clinical significance and strain specificity of neutralizing antibody to the human immunodeficiency virus","volume":"156","author":"Prince","year":"1987","journal-title":"J Inf Dis"},{"key":"2022011703312956800_b92","doi-asserted-by":"crossref","first-page":"5301","DOI":"10.1128\/jvi.64.11.5301-5305.1990","article-title":"Antibodies to the primary immunodominant domain of human immunodeficiency virus type I (HIV-1) glycoprotein gp41 enhance HIV-1 infection in vitro","volume":"64","author":"Robinson","year":"1990","journal-title":"J Virol"},{"key":"2022011703312956800_b93","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1126\/science.2972065","article-title":"Antibody-enhanced infection by HIV-I via Fc receptor-mediated entry","volume":"242","author":"Takeda","year":"1988","journal-title":"Science"},{"key":"2022011703312956800_b94","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1128\/jvi.64.4.1437-1440.1990","article-title":"Serum enhancement of human immunodeficiency virus infection correlates with disease in HIV-infected individuals","volume":"64","author":"Homsy","year":"1990","journal-title":"J Virol"},{"key":"2022011703312956800_b95","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1128\/jvi.63.2.584-590.1989","article-title":"Antigenic specificity of antibody-dependent cell-mediated cytotoxicity directed against human immunodeficiency virus in antibody-positive sera","volume":"63","author":"Koup","year":"1989","journal-title":"J Virol"},{"key":"2022011703312956800_b96","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1089\/aid.1987.3.409","article-title":"Anti-gp120 antibodies from HIV seropositive individuals mediate broadly reactive anti-HI V ADCC","volume":"3","author":"Lyerly","year":"1987","journal-title":"AIDS Res Hum Retroviruses"},{"key":"2022011703312956800_b97","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1093\/infdis\/157.6.1260","article-title":"Antibody-dependent cellular cytotoxicity specific for the envelope antigens of human immunodeficiency virus","volume":"157","author":"Shepp","year":"1988","journal-title":"J Infect Dis"},{"key":"2022011703312956800_b98","doi-asserted-by":"crossref","first-page":"2263","DOI":"10.4049\/jimmunol.139.7.2263","article-title":"Antibody-dependent cellular cytotoxicity-inducing antibodies against human immunodeficiency virus","volume":"139","author":"Ljunggren","year":"1987","journal-title":"J Immunol"},{"key":"2022011703312956800_b99","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1093\/infdis\/155.4.626","article-title":"Patterns of antibody response in individuals infected with the human immunodeficiency virus","volume":"155","author":"Pan","year":"1987","journal-title":"J Infect Dis"},{"key":"2022011703312956800_b100","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1089\/aid.1991.7.637","article-title":"Immune response to HIV p24 core protein during the early phases of human immunodeficiency virus infection","volume":"7","author":"McRae","year":"1991","journal-title":"AIDS Res Hum Retroviruses"},{"key":"2022011703312956800_b101","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1126\/science.2986291","article-title":"Virus envelope protein of HTLV-III represents major target antigen for antibodies in AIDS patients","volume":"228","author":"Barin","year":"1985","journal-title":"Science"},{"key":"2022011703312956800_b102","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1089\/aid.1990.6.1183","article-title":"Search for epitope-specific antibody responses to the human immunodeficiency virus (HI V-1) envelope glycoproteins signifying resistance to disease development","volume":"6","author":"Neurath","year":"1990","journal-title":"AIDS Res Hum Retroviruses"},{"key":"2022011703312956800_b103","first-page":"157","article-title":"Human antibody response to a strain-specific HIV-1 gp120 epitope associated with cell fusion inhibition","volume":"2","author":"Goudsmit","year":"1988","journal-title":"AIDS"},{"key":"2022011703312956800_b104","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1097\/00002030-198804000-00004","article-title":"HIV-2 antisera crossneutralize HIV-1","volume":"2","author":"Weiss","year":"1988","journal-title":"AIDS"},{"key":"2022011703312956800_b105","doi-asserted-by":"crossref","first-page":"3445","DOI":"10.1073\/pnas.87.9.3445","article-title":"Vertical transmission of human immunodeficiency virus is correlated with the absence of high-affinity\/avidity maternal antibodies to the gp120 principal neutralizing domain","volume":"87","author":"Devash","year":"1990","journal-title":"Proc Natl Acad Sci USA"},{"key":"2022011703312956800_b106","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1016\/S0140-6736(89)91965-X","article-title":"Mother-to-infant transmission of human immunodeficiency virus type 1: association with prematurity or low anti-gp120","volume":"ii","author":"Goedert","year":"1989","journal-title":"Lancet"},{"key":"2022011703312956800_b107","doi-asserted-by":"crossref","first-page":"8055","DOI":"10.1073\/pnas.86.20.8055","article-title":"Presence of maternal antibodies to human immunodeficiency virus envelope glycoprotein gp120 epitopes correlates with the uninfected status of children born to seropositive mothers","volume":"86","author":"Rossi","year":"1989","journal-title":"Proc Natl Acad Sci USA"},{"key":"2022011703312956800_b108","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1097\/00002030-199103000-00003","article-title":"Neutralizing and complement-dependent enhancing antibodies in different stages of HIV infection","volume":"5","author":"Toth","year":"1991","journal-title":"AIDS"},{"key":"2022011703312956800_b109","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1097\/00002030-199105000-00006","article-title":"Absence of a clinical correlation for complement-mediated, infection-enhancing antibodies in plasma or sera from HIV-1-infected individuals","volume":"5","author":"Montefiori","year":"1991","journal-title":"AIDS"},{"key":"2022011703312956800_b110","doi-asserted-by":"crossref","first-page":"3809","DOI":"10.4049\/jimmunol.142.11.3809","article-title":"IgG subclass response to a transmembrane protein (gp41) peptide in HIV infection","volume":"142","author":"Chiodi","year":"1989","journal-title":"J Immunol"},{"key":"2022011703312956800_b111","doi-asserted-by":"crossref","first-page":"4027","DOI":"10.4049\/jimmunol.139.12.4027","article-title":"Characterization and epitope mapping of a human monoclonal antibody reactive with the envelope glycoprotein of human immunodeficiency virus","volume":"139","author":"Banapour","year":"1987","journal-title":"J Immunol"},{"key":"2022011703312956800_b112","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/0090-1229(91)90141-V","article-title":"IgG subclass response to human immunodeficiency virus-1 antigens: Lack of IgG2 response to gp41 correlates with clinical manifestation of disease","volume":"58","author":"Lal","year":"1991","journal-title":"Clin Immunol Immunopathol"},{"key":"2022011703312956800_b113","first-page":"1326","article-title":"IgA and IgM in amniotic fluid of HIV-positive women: anti-HlV reactivity and association with immune complexes","volume-title":"VIIth International Conference on AIDS Florence","author":"Calvelli","year":"1621 1991"},{"key":"2022011703312956800_b114","first-page":"1340","article-title":"Immunoblotting analysis of IgA and IgM antibody to HIV-1 polypeptides in seropositive children","volume-title":"VIIth International Conference on AIDS Florence","author":"Furlini","year":"1621 1991"},{"key":"2022011703312956800_b115","first-page":"1314","article-title":"A new serological marker for the diagnosis of early HIV-1 infection","volume-title":"VIIth International Conference on AIDS Florence","author":"Szewczuk","year":"1621 1991"},{"key":"2022011703312956800_b116","first-page":"1138","article-title":"Functional properties of anti-idiotypic antibodies to human anti-gp120 antibodies","volume-title":"VIIth International Conference on AIDS Florence","author":"Corre","year":"1621 1991"},{"key":"2022011703312956800_b117","doi-asserted-by":"crossref","first-page":"4703","DOI":"10.1128\/jvi.62.12.4703-4711.1988","article-title":"Epitope mapping of the human immunodeficiency virus type 1 gp120 with monoclonal antibodies","volume":"62","author":"Dowbenko","year":"1988","journal-title":"J Virol"},{"key":"2022011703312956800_b118","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1099\/0022-1317-68-6-1543","article-title":"Characterization of monoclonal antibodies against the human immunodeficiency virus (HIV) gag products and their use in monitoring HIV isolate variation","volume":"68","author":"Ferns","year":"1987","journal-title":"J Virol"},{"key":"2022011703312956800_b119","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/0161-5890(90)90163-T","article-title":"Epitope mapping of the HIV-1 gag region with monoclonal antibodies","volume":"27","author":"Hinkula","year":"1990","journal-title":"Mol Immunol"},{"key":"2022011703312956800_b120","article-title":"Monoclonal antibodies to the human immunodeficiency virus","volume-title":"M.Phil, thesis, Edinburgh University","author":"Pryde","year":"1991"},{"key":"2022011703312956800_b121","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1128\/jvi.64.2.936-940.1990","article-title":"A monoclonal antibody to human immunodeficiency virus type 1 which mediates cellular cytotoxicity and neutralization","volume":"64","author":"Broliden","year":"1990","journal-title":"J Virol"},{"key":"2022011703312956800_b122","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/0042-6822(88)90674-5","article-title":"Neutralization of diverse HIV-1 strains by monoclonal antibodies raised against a gp41 synthetic peptide","volume":"165","author":"Dalgleish","year":"1988","journal-title":"Virology"},{"key":"2022011703312956800_b123","first-page":"940","article-title":"Monoclonal antibodies that neutralize HIV-1 virus and inhibit syncytium formation by infected cells","volume":"5","author":"Fung","year":"1987","journal-title":"Biotechnology"},{"key":"2022011703312956800_b124","doi-asserted-by":"crossref","first-page":"2107","DOI":"10.1128\/jvi.62.6.2107-2114.1988","article-title":"Characterization of a human immunodeficiency virus neutralizing monoclonal antibody and mapping of the neutralization epitope","volume":"62","author":"Matsushita","year":"1988","journal-title":"J Virol"},{"key":"2022011703312956800_b125","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1128\/jvi.63.1.267-272.1989","article-title":"Human immunodeficiency virus type 1\u2013neutralizing monoclonal antibodies which react with p17 core protein: characterization and epitope mapping","volume":"63","author":"Papsidero","year":"1989","journal-title":"J Virol"},{"key":"2022011703312956800_b126","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1097\/00002030-198802000-00004","article-title":"Neutralizing monoclonal antibodies to the AIDS virus","volume":"2","author":"Thomas","year":"1988","journal-title":"AIDS"},{"key":"2022011703312956800_b127","doi-asserted-by":"crossref","first-page":"3240","DOI":"10.4049\/jimmunol.145.10.3240","article-title":"Generation of neutralization-resistant HIV-1 in vitro due to amino acid interchanges of third hypervariable env region","volume":"145","author":"Masuda","year":"1990","journal-title":"J Immunol"},{"key":"2022011703312956800_b128","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1097\/00002030-198912000-00001","article-title":"Characterization of HIV-I neutralization escape mutants","volume":"3","author":"McKeating","year":"1989","journal-title":"AIDS"},{"key":"2022011703312956800_b129","doi-asserted-by":"crossref","first-page":"3306","DOI":"10.4049\/jimmunol.137.10.3306","article-title":"In vitro generation of an HTLV-III variant by neutralizing antibody","volume":"137","author":"Robert-Guroff","year":"1986","journal-title":"J Immunol"},{"key":"2022011703312956800_b130","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1089\/aid.1990.6.599","article-title":"Diagnostic utility of a mouse monoclonal antibody (5-21-3) employed as a competitive probe in an immuno-assay to detect antibody to HIV-1 gp41","volume":"6","author":"Hunt","year":"1990","journal-title":"AIDS Res Hum Retroviruses"},{"key":"2022011703312956800_b131","first-page":"206","article-title":"Therapeutic monoclonal antibodies\u2014their production and application","volume":"4","author":"James","year":"1990","journal-title":"Animal Cell Biotech"},{"key":"2022011703312956800_b132","doi-asserted-by":"crossref","first-page":"278","DOI":"10.7326\/0003-4819-112-4-278","article-title":"Clinical use of intravenous immunoglobulins","volume":"112","author":"Berkman","year":"1990","journal-title":"Ann Int Med"},{"key":"2022011703312956800_b133","first-page":"135","article-title":"Therapeutic antibodies","volume-title":"Plasma and recombinant blood products in medical therapy","author":"McCann","year":"1992"},{"key":"2022011703312956800_b134","first-page":"329","article-title":"Therapeutic strategies with monoclonal antibodies and immunoconjugates","volume":"65","author":"Byers","year":"1988","journal-title":"Immunology"},{"key":"2022011703312956800_b135","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1097\/00006231-198811000-00009","article-title":"Human immunological response to mouse monoclonal antibodies in the treatment or diagnosis of malignant diseases","volume":"9","author":"Van Kroonenburgh","year":"1988","journal-title":"Nuclear Med Commun"},{"key":"2022011703312956800_b136","first-page":"267","article-title":"Lack of an immune response by Rhesus monkeys to a human monoclonal antibody","volume":"718","author":"Ostberg","year":"1987","journal-title":"Int Cong Serol"},{"key":"2022011703312956800_b137","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/0888-0786(88)90060-1","article-title":"Human monoclonal antibodies: prospects for use as passive immunotherapy","volume":"2","author":"Masuho","year":"1988","journal-title":"Serodiag Immunother Infect Dis"},{"key":"2022011703312956800_b138","doi-asserted-by":"crossref","first-page":"2869","DOI":"10.1073\/pnas.88.7.2869","article-title":"Humanized antibodies for antiviral therapy","volume":"88","author":"Co","year":"1991","journal-title":"Proc Natl Acad Sci USA"},{"key":"2022011703312956800_b139","doi-asserted-by":"crossref","first-page":"124","DOI":"10.3233\/HAB-1991-2302","article-title":"Construction of reshaped human antibodies with HIV-neutralizing activity","volume":"2","author":"Maeda","year":"1991","journal-title":"Hum Antibod Hybridomas"},{"key":"2022011703312956800_b140","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1038\/332323a0","article-title":"Reshaping human antibodies for therapy","volume":"332","author":"Riechmann","year":"1988","journal-title":"Nature"},{"key":"2022011703312956800_b141","article-title":"Passive immunization with a monoclonal antibody directed to the HIV-1 gp120 principal neutralization determinant confers protection against HIV-1 challenge in chimpanzees","volume-title":"VIIth International Conference on AIDS Florence","author":"Emini","year":"1621 1991"},{"key":"2022011703312956800_b142","first-page":"243","article-title":"Human monoclonal antibodies and engineered antibodies in the management of cancer","volume":"1","author":"James","year":"1990","journal-title":"Semin Cancer Biol"},{"key":"2022011703312956800_b143","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1093\/clinchem\/35.9.1849","article-title":"Genetically engineered antibodies","volume":"35","author":"Moore","year":"1989","journal-title":"Clin Chem"},{"key":"2022011703312956800_b144","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1016\/S0140-6736(88)90468-0","article-title":"Passive immunoneutralisation of human immunodeficiency virus in patients with advanced AIDS","volume":"ii","author":"Jackson","year":"1988","journal-title":"Lancet"},{"key":"2022011703312956800_b145","doi-asserted-by":"crossref","first-page":"9934","DOI":"10.1073\/pnas.85.23.9234","article-title":"Effects of passive immunization in patients with the acquired immunodeficiency syndrome-related complex and acquired immune deficiency syndrome","volume":"85","author":"Karpas","year":"1988","journal-title":"Proc Natl Acad Sci USA"},{"key":"2022011703312956800_b146","doi-asserted-by":"crossref","first-page":"7613","DOI":"10.1073\/pnas.87.19.7613","article-title":"Polymerase chain reaction evidence for human immunodeficiency virus 1 neutralization by passive immunization in patients with AIDS and AIDS-related complex","volume":"87","author":"Karpas","year":"1990","journal-title":"Proc Natl Acad Sci USA"},{"key":"2022011703312956800_b147","article-title":"Passive immunotherapy in AIDS: results of phase I trial","volume-title":"State of phase II trial. VIIth International Conference on AIDS Florence","author":"Vittecoq","year":"1621 1991"},{"key":"2022011703312956800_b148","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1016\/S0140-6736(87)91477-2","article-title":"Neutralization of HIV isolates by anti-idiotypic antibodies which mimic the T4 (CD4) epitope: a potential AIDS vaccine","volume":"ii","author":"Dalgleish","year":"1987","journal-title":"Lancet"},{"key":"2022011703312956800_b149","doi-asserted-by":"crossref","first-page":"2199","DOI":"10.4049\/jimmunol.145.7.2199","article-title":"Monoclonal anti-idiotypic antibody mimicking the principal neutralization site in HIV-1 gp120 induces HIV-1 neutralizing antibodies in rabbits","volume":"145","author":"Fung","year":"1990","journal-title":"J Immunol"},{"key":"2022011703312956800_b150","doi-asserted-by":"crossref","first-page":"S119","DOI":"10.1097\/00002030-198800001-00018","article-title":"Perspectives on developing anti-idiotype-based vaccine for controlling HIV infection","volume":"2","author":"Kennedy","year":"1988","journal-title":"AIDS"},{"key":"2022011703312956800_b151","article-title":"Idiotype matching in AIDS by using monoclonal anti-idiotypic antibodies against human HIV-specific antibodies","volume-title":"VIIth International Conference on AIDS Florence","author":"Muller","year":"1621 1991"},{"key":"2022011703312956800_b152","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1002\/eji.1830060713","article-title":"Derivation of specific antibody-producing tissue culture and tumor lines by cell fusion","volume":"6","author":"Kohler","year":"1976","journal-title":"Eur J Immunol"},{"key":"2022011703312956800_b153","first-page":"1","article-title":"Human monoclonal antibodies: their potential, problems and prospects","volume-title":"Monoclonal antibodies: production and application","author":"Boyd","year":"1989"},{"key":"2022011703312956800_b154","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/0022-1759(87)90170-0","article-title":"Human monoclonal antibody production. Current status and future prospects","volume":"100","author":"James","year":"1987","journal-title":"J Immunol Methods"},{"key":"2022011703312956800_b155","doi-asserted-by":"crossref","first-page":"959","DOI":"10.4049\/jimmunol.135.2.959","article-title":"Relationship between immunoglobulin production and immortalization by Epstein Barr virus","volume":"135","author":"Tosato","year":"1985","journal-title":"J Immunol"},{"key":"2022011703312956800_b156","doi-asserted-by":"crossref","first-page":"6651","DOI":"10.1073\/pnas.79.21.6651","article-title":"Human hybridomas constructed with antigen-specific, EBV-transformed cell lines","volume":"79","author":"Kozbor","year":"1982","journal-title":"Proc Natl Acad Sci USA"},{"key":"2022011703312956800_b157","doi-asserted-by":"crossref","first-page":"3238","DOI":"10.1073\/pnas.88.8.3238","article-title":"Production of site-selected neutralizing human monoclonal antibodies against the third variable domain of the human immunodeficiency virus type 1 envelope glycoprotein","volume":"88","author":"Gorny","year":"1991","journal-title":"Proc Natl Acad Sci USA"},{"key":"2022011703312956800_b158","first-page":"325","article-title":"Human monoclonal antibodies against a recombinant HIV envelope antigen produced by primary in vitro immunization: characterization and epitope mapping","volume":"68","author":"Ohlin","year":"1989","journal-title":"Immunology"},{"key":"2022011703312956800_b159","first-page":"347","article-title":"Making novel antibodies by expressing transfected immunoglobulin genes","volume":"3","author":"Neuberger","year":"1985","journal-title":"Trends Biotechnol"},{"key":"2022011703312956800_b160","first-page":"214","article-title":"Chimeric antibodies","volume":"4","author":"Oi","year":"1986","journal-title":"Bio\/Techniques"},{"key":"2022011703312956800_b161","doi-asserted-by":"crossref","first-page":"2432","DOI":"10.1073\/pnas.88.6.2432","article-title":"Generation of diverse high-affinity human monoclonal antibodies by repertoire cloning","volume":"88","author":"Persson","year":"1991","journal-title":"Proc Natl Acad Sci USA"},{"key":"2022011703312956800_b162","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1089\/aid.1989.5.73","article-title":"Human monoclonal antibody against a gag-coded protein of human immunodeficiency virus produced by a stable EBV-transformed cell clone","volume":"5","author":"Amadori","year":"1989","journal-title":"AIDS Res Hum Retroviruses"},{"key":"2022011703312956800_b163","doi-asserted-by":"crossref","first-page":"941","DOI":"10.4049\/jimmunol.140.3.941","article-title":"Human monoclonal antibody directed against gag gene products of the human immunodeficiency virus","volume":"140","author":"Evans","year":"1988","journal-title":"J Immunol"},{"key":"2022011703312956800_b164","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1073\/pnas.86.5.1624","article-title":"Generation of human monoclonal antibodies to human immunodeficiency virus","volume":"86","author":"Gorny","year":"1989","journal-title":"Proc Natl Acad Sci USA"},{"key":"2022011703312956800_b165","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/0022-1759(88)90206-2","article-title":"The high efficient, human B cell immortalizing heteromyeloma CB-F7\u2014production of human monoclonal antibodies to human immunodeficiency virus","volume":"106","author":"Grunow","year":"1988","journal-title":"J Immunol Methods"},{"key":"2022011703312956800_b166","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1097\/00002030-199001000-00002","article-title":"Production and characterization of human monoclonal antibodies against core protein p25 and transmembrane glycoprotein gp41 of HIV-1","volume":"4","author":"Prigent","year":"1990","journal-title":"AIDS"},{"key":"2022011703312956800_b167","doi-asserted-by":"crossref","first-page":"iii","DOI":"10.1016\/0024-3205(89)90030-1","article-title":"A hybridoma producing human monoclonal antibody specific for glycoprotein 120kDa of human immunodeficiency virus (HIV-1)","volume":"45","author":"Lake","year":"1989","journal-title":"Life Sci"},{"key":"2022011703312956800_b168","doi-asserted-by":"crossref","first-page":"3967","DOI":"10.4049\/jimmunol.143.12.3967","article-title":"A chimeric mouse-human antibody that retains specificity for HIV gp120 and mediates the lysis of HIV-infected cells","volume":"143","author":"Liou","year":"1989","journal-title":"J Immunol"},{"key":"2022011703312956800_b169","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1128\/jvi.65.1.489-493.1991","article-title":"Conformational epitope on gp120 important in CD4 binding and human immunodeficiency virus type 1 neutralization identified by a human monoclonal antibody","volume":"65","author":"Ho","year":"1991","journal-title":"J Virol"},{"key":"2022011703312956800_b170","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1089\/aid.1990.6.567","article-title":"Identification of conserved and variant epitopes of human immunodeficiency virus type 1 (HIV-1) gp120 by human monoclonal antibodies produced by EBV-transformed cell lines","volume":"6","author":"Robinson","year":"1990","journal-title":"AIDS Res Hum Retroviruses"},{"key":"2022011703312956800_b171","doi-asserted-by":"crossref","first-page":"8597","DOI":"10.1073\/pnas.87.21.8597","article-title":"Human monoclonal antibody that recognizes the V3 region of human immunodeficiency virus gp 120 and neutralizes the human T-lymphotropic virus type IIImn strain","volume":"87","author":"Scott","year":"1990","journal-title":"Proc Natl Acad Sci USA"},{"key":"2022011703312956800_b172","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/0923-2516(91)90010-Z","article-title":"A human monoclonal antibody against the CD4\u2013binding site of HIV-1 gp120 exhibits potent, broadly neutralizing activity","volume":"142","author":"Tilley","year":"1991","journal-title":"Res Virol"},{"key":"2022011703312956800_b173","article-title":"Biological features of human monoclonal antibodies directed against HIV envelope peptides","volume-title":"VIIth International Conference on AIDS Florence","author":"Desgranges","year":"1621 1991"},{"key":"2022011703312956800_b174","doi-asserted-by":"crossref","first-page":"4325","DOI":"10.4049\/jimmunol.146.12.4325","article-title":"An IgG human monoclonal antibody that reacts with HIV-l\/gp120, inhibits virus binding to cells, and neutralizes infection","volume":"146","author":"Posner","year":"1991","journal-title":"J Immunol"},{"key":"2022011703312956800_b175","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1111\/j.1365-2249.1991.tb05660.x","article-title":"Characterization and large production of human monoclonal antibodies against the HIV-1 envelope","volume":"83","author":"Boyer","year":"1991","journal-title":"Clin Exp Immunol"},{"key":"2022011703312956800_b176","doi-asserted-by":"crossref","first-page":"4123","DOI":"10.1128\/jvi.64.9.4123-4129.1990","article-title":"Analysis of a highly immunodominant epitope in the human immunodeficiency virus type 1 transmembrane glycoprotein, gp41, defined by a human monoclonal antibody","volume":"64","author":"Bugge","year":"1990","journal-title":"J Virol"},{"key":"2022011703312956800_b177","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1016\/S0140-6736(88)91737-0","article-title":"Monoclonal antibodies to HIV in a non-infected, immunized volunteer","volume":"i","author":"Desgranges","year":"1988","journal-title":"Lancet"},{"key":"2022011703312956800_b178","doi-asserted-by":"crossref","first-page":"3276","DOI":"10.4049\/jimmunol.145.10.3276","article-title":"Identification of sites within gp41 that serve as targets for antibody-dependent cellular cytotoxicity by using human monoclonal antibodies","volume":"145","author":"Tyler","year":"1990","journal-title":"J Immunol"},{"key":"2022011703312956800_b179","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1089\/aid.1990.6.381","article-title":"Production and characterization of a human monoclonal antibody, reactive with a conserved epitope on gp41 of human immunodeficiency virus type 1","volume":"6","author":"Teeuwsen","year":"1990","journal-title":"AIDS Res Hum Retroviruses"},{"key":"2022011703312956800_b180","first-page":"323","article-title":"Human monoclonal antibodies to HIV-1: cross-reactions with gag and env products","volume":"78","author":"Pollock","year":"1989","journal-title":"Clin Exp Immunol"},{"key":"2022011703312956800_b181","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1038\/332728a0","article-title":"A group specific anamnestic immune reaction against HIV-1 induced by a candidate vaccine against AIDS","volume":"332","author":"Zagury","year":"1988","journal-title":"Nature"},{"key":"2022011703312956800_b182","first-page":"213","article-title":"The optimal technological approach to the development of human hybridomas","volume":"4","author":"Dorfman","year":"1985","journal-title":"J Biol Response Mod"},{"key":"2022011703312956800_b183","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/0022-1759(86)90200-0","article-title":"In vitro stimulation prior to fusion generates antigen-binding human-human hybridomas","volume":"93","author":"Wasserman","year":"1986","journal-title":"J Immunol Methods"},{"key":"2022011703312956800_b184","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/0022-1759(89)90219-6","article-title":"Strategy for the production of human monoclonal antibodies using in vitro activated B cells","volume":"123","author":"Borrebaeck","year":"1989","journal-title":"J Immunol Methods"},{"key":"2022011703312956800_b185","doi-asserted-by":"crossref","first-page":"4832","DOI":"10.1128\/jvi.65.9.4832-4838.1991","article-title":"Epitope mapping of two immunodominant domains of gp41, the transmembrane protein of human immunodeficiency virus type 1, using ten human monoclonal antibodies","volume":"65","author":"Xu","year":"1991","journal-title":"J Virol"},{"key":"2022011703312956800_b186","doi-asserted-by":"crossref","first-page":"4169","DOI":"10.1128\/jvi.65.8.4169-4176.1991","article-title":"Two immunodominant domains of gp41 bind antibodies which enhance human immunodeficiency virus type 1 infection in vitro","volume":"65","author":"Robinson","year":"1991","journal-title":"J Virol"},{"key":"2022011703312956800_b187","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1097\/00002030-199107000-00017","article-title":"An inhibition enzyme immunoassay using a human monoclonal antibody (K14) reactive with gp41 ofHIV-1 for the serology of HIV-1 infections","volume":"5","author":"Teeuwsen","year":"1991","journal-title":"AIDS"},{"key":"2022011703312956800_b188","article-title":"Presentation of HIV env glycoprotein to specific human T clones is enhanced by poly and monoclonal antibodies","volume-title":"VIIth International Conference on AIDS, Florence","author":"Li Pira","year":"1621 1991"},{"key":"2022011703312956800_b189","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/0090-1229(91)90081-K","article-title":"Epitopes of human immunodeficiency virus type 1 (HIV-1) envelope glycoproteins recognized by antibodies in the sera of HIV-infected individuals","volume":"59","author":"Krowka","year":"1991","journal-title":"Clin Immunol Immunopathol"},{"key":"2022011703312956800_b190","doi-asserted-by":"crossref","first-page":"4315","DOI":"10.4049\/jimmunol.146.12.4315","article-title":"In vitro efficacy of anti-HIV immunotoxins targeted by various antibodies to the envelope protein","volume":"146","author":"Pincus","year":"1991","journal-title":"J Immunol"},{"key":"2022011703312956800_b191","article-title":"Antibodies against gp41 epitope responsible for antibody enhanced infection of HIV increase over time","volume-title":"VIIth International Conference on AIDS. Florence","author":"Monell","year":"1621 1991"},{"key":"2022011703312956800_b192","doi-asserted-by":"crossref","first-page":"3185","DOI":"10.1073\/pnas.87.8.3185","article-title":"Human monoclonal antibodies to the human immunodeficiency virus type 1 (HIV-1) transmembrane glycoprotein gp41 enhance HIV-1 infection in vitro","volume":"87","author":"Robinson","year":"1990","journal-title":"Proc Natl Acad Sci USA"},{"key":"2022011703312956800_b193","doi-asserted-by":"crossref","first-page":"2639","DOI":"10.1128\/jvi.61.8.2639-2641.1987","article-title":"Fine mapping of an immunodominant domain in the transmembrane protein of human immunodeficiency virus","volume":"61","author":"Gnann","year":"1987","journal-title":"J Virol"},{"key":"2022011703312956800_b194","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1097\/00002030-198804000-00008","article-title":"Highly immuno-reactive antigenic site in a hydrophobic domain of HIV-1 gp41 which remains undetectable with conventional immunochemical methods","volume":"2","author":"Narvanen","year":"1988","journal-title":"AIDS"},{"key":"2022011703312956800_b195","doi-asserted-by":"crossref","first-page":"1556","DOI":"10.1126\/science.3006246","article-title":"Antiserum to a synthetic peptide recognizes the HTLV-III envelope glycoprotein","volume":"231","author":"Kennedy","year":"1986","journal-title":"Science"},{"key":"2022011703312956800_b196","article-title":"Structure and function of a discontinuous gp120 epitope recognized by a broadly-reactive neutralizing human monoclonal antibody","volume-title":"VIIth International Conference on AIDS, Florence","author":"Thali","year":"1621 1991"},{"key":"2022011703312956800_b197","article-title":"Human monoclonal antibodies (HumAbs) to the V3 loop of HIV-1 react with divergent strains","volume-title":"VIIth International Conference on AIDS, Florence","author":"Gorny","year":"1621 1991"},{"key":"2022011703312956800_b198","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1126\/science.2830667","article-title":"Second conserved domain of gp120 is important for HIV infectivity and antibody neutralization","volume":"239","author":"Ho","year":"1988","journal-title":"Science"},{"key":"2022011703312956800_b199","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.1126\/science.1703322","article-title":"Broadly neutralizing antibodies elicited by the hypervariable neutralizing determinant of HIV-1","volume":"250","author":"Javaherian","year":"1990","journal-title":"Science"},{"key":"2022011703312956800_b200","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1016\/0092-8674(87)90524-1","article-title":"Delineation of a region of the human immunodeficiency virus type 1 gp120 glycoprotein critical for interaction with the CD4 receptor","volume":"50","author":"Lasky","year":"1987","journal-title":"Cell"},{"key":"2022011703312956800_b201","doi-asserted-by":"crossref","first-page":"2833","DOI":"10.1128\/jvi.64.6.2833-2840.1990","article-title":"Inhibition of human immunodeficiency virus (HIV) infection in vitro by anticarbohydrate monoclonal antibodies: peripheral glycosylation of HIV envelope glycoprotein gp120 may be target for virus neutralization","volume":"64","author":"Hansen","year":"1990","journal-title":"J Virol"},{"key":"2022011703312956800_b202","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/0006-291X(91)91979-M","article-title":"Recognition of human immunodeficiency virus glycoproteins by natural anti-carbohydrate antibodies in human serum","volume":"177","author":"Tomiyama","year":"1991","journal-title":"Biochem Biophys Res Comm"},{"key":"2022011703312956800_b203","doi-asserted-by":"crossref","first-page":"2889","DOI":"10.1099\/0022-1317-71-12-2889","article-title":"Glycosylation governs the binding of antipeptide antibodies to regions of hypervariable amino acid sequence within recombinant gp120 of human immunodeficiency virus type 1","volume":"71","author":"Davis","year":"1990","journal-title":"J Gen Virol"},{"key":"2022011703312956800_b204","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/0022-1759(90)90398-F","article-title":"An anti-p24 monoclonal antibody shows cross-reactivity with multiple HIV-1 proteins","volume":"132","author":"Liang","year":"1990","journal-title":"J Immunol Methods"},{"key":"2022011703312956800_b205","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/0022-1759(89)90208-1","article-title":"Application of a human monoclonal antibody in a rapid competitive anti-HIV ELISA","volume":"116","author":"Dopel","year":"1989","journal-title":"J Immunol Methods"},{"key":"2022011703312956800_b206","doi-asserted-by":"crossref","first-page":"1987","DOI":"10.1073\/pnas.86.6.1987","article-title":"Human immunodeficiency virus-infected T cells and monocytes are killed by monoclonal human anti-gp41 antibodies coupled to ricin A chain","volume":"86","author":"Till","year":"1989","journal-title":"Proc Natl Acad Sci USA"},{"key":"2022011703312956800_b207","first-page":"609","article-title":"Immunoconjugates containing ricin A chain and either human anti-gp41 or CD4 kill H9 cells infected with different isolates of HIV 1 but do not inhibit normal T or B cell function","volume":"3","author":"Till","year":"1990","journal-title":"J AIDS"},{"key":"2022011703312956800_b208","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/0022-1759(90)90109-9","article-title":"Development of microfusion techniques to generate human hybridomas","volume":"134","author":"Foung","year":"1990","journal-title":"J Immunol Methods"}],"container-title":["Clinical and Experimental Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2249.1992.tb03061.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/cei\/article-pdf\/88\/2\/189\/42213234\/j.1365-2249.1992.tb03061.x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/cei\/article-pdf\/88\/2\/189\/42213234\/j.1365-2249.1992.tb03061.x.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,23]],"date-time":"2025-02-23T10:40:40Z","timestamp":1740307240000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/cei\/article\/88\/2\/189\/6488243"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1992,5]]},"references-count":208,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2008,6,28]]},"published-print":{"date-parts":[[2008,6,28]]}},"URL":"https:\/\/doi.org\/10.1111\/j.1365-2249.1992.tb03061.x","relation":{},"ISSN":["1365-2249","0009-9104"],"issn-type":[{"value":"1365-2249","type":"electronic"},{"value":"0009-9104","type":"print"}],"subject":[],"published-other":{"date-parts":[[1992,5]]},"published":{"date-parts":[[1992,5]]}}}